Tower Research Capital (TRC)’s Cadrenal Therapeutics CVKD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.64K Buy
+136
New +$1.64K ﹤0.01% 4769
2025
Q1
Sell
-368
Closed -$5.33K 5287
2024
Q4
$5.33K Buy
+368
New +$5.33K ﹤0.01% 4307
2024
Q3
Sell
-644
Closed -$4.54K 5743
2024
Q2
$4.54K Buy
644
+9
+1% +$63 ﹤0.01% 4770
2024
Q1
$5.81K Buy
635
+69
+12% +$631 ﹤0.01% 4485
2023
Q4
$6.29K Buy
566
+1
+0.2% +$11 ﹤0.01% 4762
2023
Q3
$5.76K Buy
565
+547
+3,039% +$5.58K ﹤0.01% 4691
2023
Q2
$408 Sell
18
-22
-55% -$499 ﹤0.01% 5630
2023
Q1
$1K Buy
+40
New +$1K ﹤0.01% 5515